Selank is a synthetic peptide developed in Russia that reduces anxiety, modulates immune function, and may improve cognitive performance. It works primarily by blocking the enzymes that break down your body’s natural feel-good molecules called enkephalins, which are part of the same system targeted by opioids but without the addictive properties. Selank is not approved by the FDA in the United States, though it has been used clinically in Russia as a nasal spray.
How Selank Works in the Body
Selank is a seven-amino-acid chain (Thr-Lys-Pro-Arg-Pro-Gly-Pro) designed as a stabilized version of a naturally occurring immune molecule called tuftsin. Its primary mechanism involves inhibiting the enzymes that normally break down enkephalins in your blood. Enkephalins are small molecules your body produces that bind to opioid receptors, reducing pain and creating a sense of calm. Normally they’re destroyed within seconds, but Selank slows that process down, allowing enkephalin levels to rise.
In laboratory testing, Selank inhibited enkephalin breakdown in a dose-dependent manner, with an IC50 of 15 micromoles. It outperformed established enzyme-blocking compounds like bacitracin and puromycin. This ability to preserve your body’s own calming molecules is considered the primary driver of its anti-anxiety effects.
One unusual feature of Selank is the mismatch between how quickly it disappears from the blood and how long its effects last. In vitro, the peptide has a half-life of roughly two minutes. Yet it accumulates in deeper brain structures involved in emotion and memory, where its activity persists for 20 to 24 hours after a single dose. This means the peptide itself is rapidly broken down, but its downstream effects on brain chemistry continue throughout the day.
Anti-Anxiety Effects
The most studied use of Selank is for generalized anxiety and phobic disorders. In a clinical comparison with phenazepam (a benzodiazepine widely prescribed in Russia), Selank demonstrated a pronounced anti-anxiety effect along with mild cognitive-enhancing properties. Notably, the anxiolytic effect continued for about a week after the last dose, suggesting it doesn’t just mask symptoms while you’re taking it but creates a more lasting shift in baseline anxiety levels.
Researchers also reported that Selank had a positive impact on quality of life scores in patients with anxiety disorders. Unlike benzodiazepines, which commonly cause drowsiness, impaired coordination, and dependence, Selank does not appear to produce sedation or the cognitive dulling that makes benzodiazepines difficult for daily functioning. The absence of these side effects is likely tied to its indirect mechanism: rather than forcing a change in brain signaling the way a benzodiazepine does, Selank amplifies a system your brain already uses to regulate stress.
Immune System Effects
Selank’s parent molecule, tuftsin, is a fragment of an immune protein, so it’s not surprising that Selank also affects immune function. Under chronic stress conditions, the body ramps up production of inflammatory signaling molecules called cytokines. In animal studies using a 20-day social stress model, stressed animals showed significant increases in several pro-inflammatory cytokines, including IL-1β, IL-6, TNF-α, and TGF-β1.
When Selank was administered daily during the stress period at a dose of 100 mcg/kg, it brought nearly all of those elevated inflammatory markers back down to baseline levels. It also restored levels of IL-4, an anti-inflammatory cytokine that stress had suppressed. This matters because chronic low-grade inflammation is increasingly recognized as a contributor to depression, anxiety, fatigue, and a range of physical health problems. By dampening this stress-driven inflammatory response, Selank may address both the psychological and physiological consequences of prolonged stress.
Cognitive Effects
Clinical researchers have described Selank as having a “mild nootropic” effect, meaning it appears to support memory and mental clarity, though the evidence here is less robust than for its anti-anxiety properties. The cognitive benefits may be partly explained by anxiety reduction itself. High anxiety impairs working memory, attention, and decision-making, so a calmer nervous system naturally performs better on cognitive tasks. Selank’s accumulation in brain regions associated with memory formation also suggests a more direct role, though the precise mechanisms are still being mapped out.
Regulatory Status and Safety
In Russia, Selank has been used in clinical practice for anxiety disorders and is available as a nasal spray. In the United States, it has no FDA approval and is not available by prescription. The FDA has flagged selank acetate as a bulk drug substance that may present safety risks when used in compounding pharmacies, citing concerns about immunogenicity (the possibility that the body could mount an immune response against the peptide) due to potential aggregation and impurities in compounded products. The agency has also stated that it lacks sufficient safety data on selank acetate administered to humans.
This means that Selank products sold in the U.S. exist in a regulatory gray area. They’re typically marketed as research chemicals or peptides rather than as medications. Quality control varies significantly between suppliers, and without FDA oversight, there’s no guarantee that what’s on the label matches what’s in the vial. Most of the clinical research on Selank has been conducted in Russia, and while the findings are promising, the body of evidence is smaller and less diverse than what would be required for regulatory approval in the U.S. or Europe.
How Selank Is Typically Used
In clinical settings where it’s prescribed, Selank is administered as a nasal spray. The nasal route allows the peptide to bypass the digestive system, where it would be rapidly destroyed, and reach the brain more directly. Some users outside of clinical settings also use subcutaneous injection, though this is less studied and raises the immunogenicity concerns the FDA has noted.
Because the peptide itself breaks down within minutes but its brain-level effects last up to 24 hours, it doesn’t require constant re-dosing throughout the day. The clinical trial comparing it to phenazepam used a standard course of treatment rather than indefinite daily use, and the persistence of benefits for a week after stopping suggests it may work best in defined treatment periods rather than as a lifelong daily medication.